Bullseye Biosciences
Biotechnology company developing precision diagnostics and therapeutic solutions, co-founded by Yale pathologist David Rimm.
Website
https://www.bullseyebio.comLocation
San Francisco Bay Area, California, USA
Founded
2020
Investors
1
Categories
biotech, diagnostics, precision-medicine, oncology
Notes
Bullseye Biosciences is a biotechnology company focused on developing precision diagnostic and therapeutic solutions. The company was co-founded by David Rimm, a renowned pathologist and professor at Yale School of Medicine, known for his expertise in quantitative pathology and biomarker development.
Team
- David Rimm, M.D., Ph.D. - Co-founder & Chief Scientific Officer
- LinkedIn: linkedin.com/in/davidrimm
- Professor of Pathology at Yale School of Medicine
Additional Research Findings
- Co-founded by Yale pathologist David Rimm
- Focus on precision diagnostics and therapeutics
- Bay Area, California based
- Leveraging expertise in quantitative pathology
- Biomarker development capabilities
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Illumina Ventures | San Francisco, California, USA | biotech-focused | seedseries-a+1 | 32 |